Carbamazepine Tablet
Product Images NDC 51407-215

4 FDA label images from Golden State Medical Supply, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Carbamazepine (NDC 51407-215). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Carbamazepine 01)

Chemical Structure (Carbamazepine 01)
Chemical structure of Carbamazepine. The diagram depicts the molecular arrangement of atoms in the active ingredient Carbamazepine, showing its characteristic fused ring system and amide group.*
FDA Label Image

Table 1 (Table 1)

Table 1 (Table 1)
A data table titled 'Risk by Indication for Antiepileptic Drugs in the Pooled Analysis' showing columns for indication, placebo patients with events per 1,000 patients, drug patients with events per 1,000 patients, relative risk comparing drug to placebo, and risk difference of additional drug patients with events per 1,000 patients. Indications include epilepsy, psychiatric, other, and total.*
FDA Label Image

Table (Table 2)

Table (Table 2)
A dosage information table for Carbamazepine oral tablets showing initial, subsequent, and maximum daily doses by indication and age group. It includes dosing details for epilepsy under 6 years, 6 to 12 years, over 12 years, and trigeminal neuralgia, differentiating between conventional tablets, extended-release tablets, and suspensions with specific dose increments and frequency.*
FDA Label Image

51407-215-01lb.jpg (51407 215 01lb)

51407-215-01lb.jpg (51407 215 01lb)
Label for Carbamazepine tablets, USP, 200 mg, containing 100 tablets in the package. The label includes the NDC 51407-215-01 and instructions for pharmacists to dispense the medication guide. The labeler is Golden State Medical Supply, Inc., with manufacturing by Taro Pharmaceutical Industries Ltd and marketing by GSMS, Incorporated. Storage instructions and warnings to protect from moisture and keep out of children's reach are also present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.